PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION

Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including dabigatran etexilate, in the stroke prevention in patients with atrial fibrillation are considered. Factors that influence the choice of dabigatran dose in different individuals are discussed. Dabigatran...

Full description

Saved in:
Bibliographic Details
Main Authors: E. D. Kosmacheva (Author), S. G. Kanorskiy (Author), A. A. Kastanayan (Author), N. V. Haylo (Author), D. B. Goltyapin (Author), E. A. Lipnitskaya (Author), M. E. Statsenko (Author)
Format: Book
Published: Столичная издательская компания, 2015-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including dabigatran etexilate, in the stroke prevention in patients with atrial fibrillation are considered. Factors that influence the choice of dabigatran dose in different individuals are discussed. Dabigatran treatment in special conditions is considered: during stroke development; in electrical or pharmacological cardioversion; in invasive or surgical procedures; during bleeding. Possible organizational system of thromboembolic events prevention in patients with atrial fibrillation is presented.
Item Description:1819-6446
2225-3653
10.1234/1819-6446-2013-5-551-556